A Study of Pirtobrutinib (LY3527727 [LOXO-305]) Versus Placebo in Participants With Relapsing Multiple Sclerosis
Clinical trial NCT06104683 · WITHDRAWN
Trial details
- NCT number
- NCT06104683
- Sponsor
- Loxo Oncology, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2026-01-16
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.